Now that you’ve had the weekend to digest the 4Q 2018 PitchBook-NVCA Venture Monitor released last week, it’s time to dive into more trends! NVCA President & CEO, Bobby Franklin, reviewed some of the big takeaways from 2018 in his VentureBeat article over the weekend. This blog post builds on those trends and themes with data and charts from the Venture Monitor, highlighting what we think are the eight most notable ones.
With the start of the World Series this week, where the Los Angeles Dodgers and Boston Red Sox duke it out for the biggest bragging rights in baseball, we thought it would be fun to do a quick rundown of the venture ecosystems for these two U.S. startup powerhouses.
Slack, social media, and water cooler-talk has been bustling with competitive banter this week – at least this has been the case at NVCA! For those looking to share in the cheer or the tears that are sure to come over the next week, feel free to celebrate/commiserate with NVCA’s own Jeff Farrah and Stephanie Volk . In the meantime, I’m looking forward to Giants spring training come February. (more…)
Today marks the one-year anniversary of the PitchBook-NVCA partnership! It’s been a fantastic first year of getting to know the capabilities of the PitchBook Platform and the expertise of the PitchBook team, as we’ve taken NVCA’s research and data offerings to the next level. See below (and click around) for some of the highlights over the past year. (more…)
We are pleased to present the 2017 NVCA Yearbook, documenting trends and analysis of venture capital activity in the United States from the past year and capturing historical data and information about venture’s role in fueling entrepreneurship in America.
What is the NVCA Yearbook?
Now in its 20th year, the NVCA Yearbook is an annual publication that provides statistics on the size and impact of the U.S. venture industry, investments into startups, capital raised and managed by venture capital firms, and exit activity. The Yearbook is an indispensable resource for anyone working in venture capital and has long been seen as the benchmark for tracking and analyzing venture capital activity from year-to-year. (more…)
On Sunday night, the New England Patriots clash with the Atlanta Falcons in a Super Bowl matchup that pits two football franchises with wildly different recent histories. The Patriots come into the game as the most successful, and to some infamous, NFL franchise over the last 16 years. The coach/quarterback combination of Bill Belichick and Tom Brady has created one of sport’s most impressive modern dynasties, with a combined 7 Super Bowl appearances (including 4 wins so far), 14 division titles, and 214 combined regular season and playoff victories.
The Falcons by comparison have had spikes of success over the last decade and a half, with peaks of 7 playoff appearances over the last 16 seasons, but also significant valleys in 8 seasons without a winning record. However, this season the Falcons were the second seed in the NFC Conference and had one of the most explosive offenses in NFL history, rivaling the offensive firepower of the 2007 Patriots team that went undefeated in the regular season that year.
This dynamic sets up the Super Bowl as a contest between a perennial heavyweight and a scrappy contender, an empire against a rebellion, or whatever other David vs Goliath metaphor you can think of. (more…)
Earlier this month, we released the Q4 2016 PitchBook-NVCA Venture Monitor, a review of the U.S. venture capital ecosystem’s fourth quarter and year-end trends for 2016. Between the Presidential inauguration, meetings with the Trump transition team, and various other industry data releases, it has been a busy start to 2017 for NVCA. So in case you may have missed it, here are some helpful resources related to the report:
The report unpacks a large number of trends and data points on the venture industry, so we have highlighted five major trends below that caught our eye: (more…)
We just released our diversity study. Our study is different. We set out to survey all VC firms active in the U.S. to establish a benchmark of the current demographics of the industry and to take a closer look at firms’ talent management practices.
If you’ve spoken with a member of the NVCA staff over the past two years or one of our Board Members, the topic of diversity and inclusion (D&I) in the venture capital industry has likely come up. Since the launch of NVCA’s Diversity Task Force in December 2014, NVCA staff, its Board, and its members have focused on building a more inclusive innovation ecosystem. In our report Building a More Inclusive Entrepreneurial Ecosystem this summer, we outlined many proactive NVCA efforts and industry resources, highlighted a few firms who are leading the pack in terms of diversity initiatives, and referenced third-party data on D&I in VC. (more…)
Venture capital’s contribution to the technology and Internet sectors are well understood, with VC partnering with the founders of iconic brands like Facebook, Uber, and Netflix. What is not as well understood is how venture is tackling the world’s deadliest diseases and afflictions through the patient investment of capital in life science startups. A prominent example is Genentech, the world’s first biotechnology company, which was founded in 1976 by a venture capitalist and a professor at the University of California, San Francisco. Today, venture is building on past success to solve our nation’s most pressing health care crises, like lymphoma, multiple myeloma, sickle cell disease, cystic fibrosis, multiple sclerosis, and many others.
Small, venture-backed companies play a critical role in bringing groundbreaking medical innovation to market that diagnoses, treats, or cures previously intractable diseases like cancer and HIV/AIDS. These fast-growing and hungry new enterprises are responsible for a considerable amount of breakthroughs in life sciences, so much so that drug companies now rely on acquisitions for three-quarters of their drug pipelines rather than develop new products internally. In many other cases, VC-backed life science startups grow into successful enterprises of their own, with 51 having gone public in 2015. In fact, life science startups drove two-thirds of all VC-backed IPOs in 2015. (more…)
At NVCA we are committed to helping policymakers craft pro-growth policies that help startups continue to drive the U.S. economy and encourage job creation. So when we see articles that fail to understand how innovation and entrepreneurship work, it is our responsibility to correct the record. This recent article in Politico makes just this mistake and threatens to undermine public support for an important provision of the tax code that encourages investment in early stage startups.
Let us start with a couple of facts that we should all keep in mind. Twenty-five years ago, more than 90 percent of global venture capital was invested in U.S. entrepreneurs. Last year, U.S. startups attracted 54 percent of global venture capital investment as other countries continue to reform their policies to build their ecosystems and compete with our long-held leadership in the space. In addition, smaller C corporations have been vanishing. As a result, the total number of U.S. public companies have been reduced by half in only 20 years. (more…)